Top

Published in:

01-05-2010 | Case Report

Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy

Authors: Dr Gian Paolo Fadini, Enzo Manzato, Cristina Crepaldi, Saula de Kreutzenberg, Antonio Tiengo, Angelo Avogaro

Published in: Clinical Drug Investigation | Issue 5/2010

Abstract

HMG-CoA reductase inhibitors (statins) are highly effective drugs for prevention of cardiovascular events in high-risk patients. Due to the widespread prescription of these agents, special attention should be given to their rare adverse effects when these may have severe outcomes. Here, we report two cases of localized rhabdomyolysis associated with mononeuropathy in patients taking statins and suggest possible explanations for this uncommon association. Close monitoring for myopathic/neuropathic events is warranted in high-risk patients with pre-existing neuropathies who are taking statins.

Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med 2004; 164: 1427–36PubMedCrossRef

Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005; 165: 725–30PubMedCrossRef

Avogaro A, Guida P, Giorda C, et al. The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy. Nutr Metab Cardiovasc Dis 2007; 17: 32–40PubMedCrossRef

Antons KA, Williams KD, Baker SK, et al. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006; 119: 400–9PubMedCrossRef

Law M, Rudnicka AR. Statin safety: a systematic review. Am J Cardiol 2006; 97: 52C–60CPubMedCrossRef

Kiortsis DN, Filippatos TD, Mikhailidis DP, et al. Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis 2007; 195: 5–16CrossRef

Baker SK, Tarnopolsky MA. Statin-associated neuromyotoxicity. Drugs Today (Barc) 2005; 41: 267–93CrossRef

Tsivgoulis G, Spengos K, Karandreas N, et al. Presymptomatic neuromuscular disorders disclosed following statin treatment. Arch Intern Med 2006; 166: 1519–24PubMedCrossRef

Title: Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy
Authors: Dr Gian Paolo Fadini
Enzo Manzato
Cristina Crepaldi
Saula de Kreutzenberg
Antonio Tiengo
Angelo Avogaro
Publication date: 01-05-2010
Publisher: Springer International Publishing
Published in: Clinical Drug Investigation / Issue 5/2010
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI: https://doi.org/10.2165/11535470-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2010

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects

Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women

Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria

Thromboprophylaxis with the Low-Molecular-Weight Heparin Bemiparin Sodium in Elderly Medical Patients in Usual Clinical Practice

Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia

Moxifloxacin does not Alter Ciclosporin Pharmacokinetics in Transplant Patients